CIK 0001053369
- Non-accelerated filer
- Smaller reporting company
ELITE PHARMACEUTICALS INC /NV/
Sign in to watch- Ticker
- ELTP
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NJ
- Entity type
- Operating
- EIN
- 223542636
- Phone
- +1 201-750-2646
- Business address
- 165 LUDLOW AVENUE, NORTHVALE, NJ, 07647
- Former names
- ELITE PHARMACEUTICALS INC /DE/
- 4 Open-market sale 10% owner sold 100,000 shares at $0.13 ($12,520)
- 4 Open-market sale 10% owner sold 100,000 shares at $0.13 ($12,520)
- 4 Open-market sale Director sold 421,000 shares at an average $0.12 ($50,933)
- 4 Open-market sale Chief Scientific Officer sold 421,000 shares at an average $0.12 ($50,933)
- 4 Open-market sale 10% owner sold 421,000 shares at an average $0.12 ($50,933)
- 4 Open-market sale 10% owner sold 421,000 shares at an average $0.12 ($50,933)
- 4 Open-market sale Director sold 1,974,140 shares at an average $0.12 ($230,860)
- 4 Open-market sale Chief Scientific Officer sold 1,974,140 shares at an average $0.12 ($230,818)
- 4 Open-market sale 10% owner sold 1,974,140 shares at an average $0.12 ($230,818)
- 4 Open-market sale 10% owner sold 1,974,140 shares at an average $0.12 ($230,818)
- 4 Open-market sale Director sold 122,200 shares at $0.12 ($15,092)
- 4 Open-market sale Chief Scientific Officer sold 122,200 shares at $0.12 ($15,092)
- 4 Open-market sale 10% owner sold 122,200 shares at $0.12 ($15,092)
- 4 Open-market sale 10% owner sold 122,200 shares at $0.12 ($15,092)
- 4 Open-market sale Director sold 204,820 shares at an average $0.07 ($14,550)
- 4 Open-market sale Chief Scientific Officer sold 279,300 shares at an average $0.13 ($35,820)
- 4 Open-market sale 10% owner sold 931,000 shares at an average $0.13 ($119,400)
- 4 Open-market sale 10% owner sold 931,000 shares at an average $0.13 ($119,400)
- 4 Conversion Director acquired 14,485,597 shares (conversion)
- 4 Conversion Scief Scientific Officer acquired 19,753,086 shares (conversion)
Page 9 of 26 · 511 filings